5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
NEUTRAL | NEUTRAL | NEUTRAL | SELL | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | N/A | N/A | N/A | 4,078.20▼ | 4,127.20▼ |
MA10 | N/A | N/A | N/A | 4,069.10▼ | 4,122.90▼ |
MA20 | N/A | N/A | N/A | 4,113.10▼ | 4,000.25▲ |
MA50 | N/A | N/A | N/A | 4,127.94▼ | 3,664.38▲ |
MA100 | N/A | N/A | N/A | 3,998.89▲ | 3,066.40▲ |
MA200 | N/A | N/A | N/A | 3,768.82▲ | 2,245.26▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | N/A | N/A | N/A | -5.552▼ | -19.838▼ |
RSI | N/A | N/A | N/A | 45.785▼ | 53.921▲ |
STOCH | N/A | N/A | N/A | 60.545 | 55.864 |
WILL %R | N/A | N/A | N/A | -59.115 | -32.656 |
CCI | N/A | N/A | N/A | -53.000 | 15.620 |
Saturday, July 05, 2025 12:36 AM
Mark Hartley breaks down why 3i Group's one of the most profitable companies on the FTSE 100, and the risks investors need to watch out for. The post 3i Group: unravelling the finances behind one of ...
|
Friday, July 04, 2025 05:53 PM
Jayden Daniels is being compared to Robert Griffin III after a breakout rookie season, but Washington insiders and fans believe the team is built to avoid histo ...
|
Friday, July 04, 2025 02:16 AM
British drugmaker AstraZeneca (LSE: AZN) has gained European approval for Imfinzi (durvalumab) in combination with chemotherapy as a treatment for resectable muscle-invasive bladder cancer. The green ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
04/07/25 | 4,055.00 | 4,062.00 | 4,028.00 | 4,042.00 | 239,363 |
03/07/25 | 4,050.00 | 4,093.00 | 4,030.00 | 4,078.00 | 502,194 |
02/07/25 | 4,101.00 | 4,104.237 | 4,013.00 | 4,050.00 | 991,317 |
01/07/25 | 4,137.00 | 4,147.0079 | 4,064.00 | 4,101.00 | 848,234 |
30/06/25 | 4,184.00 | 4,196.7106 | 4,118.00 | 4,120.00 | 990,970 |
27/06/25 | 4,127.00 | 4,187.00 | 4,093.00 | 4,161.00 | 1,151,738 |
26/06/25 | 3,935.00 | 4,156.00 | 3,935.00 | 4,138.00 | 1,402,493 |
25/06/25 | 4,045.00 | 4,046.00 | 3,944.00 | 3,949.00 | 1,100,614 |
24/06/25 | 4,102.00 | 4,105.00 | 4,016.00 | 4,030.00 | 987,361 |
23/06/25 | 4,005.00 | 4,060.00 | 3,971.00 | 4,022.00 | 771,235 |
|
|
||||
|
|
||||
|
|